Current strategies for detection and approach to measurable residual disease in acute myeloid leukemia-Reference-Cited by-同舟云学术

Current strategies for detection and approach to measurable residual disease in acute myeloid leukemia

Published:2020-11 Issue:5 Volume:111 Page:
ISSN:0026-4806
Container-title:Minerva Medica
language:
Short-container-title:Minerva Med

Author:

Palmieri Raffaele,Buccisano Francesco,Maurillo Luca,Del Principe Maria I.,Paterno Giovangiacinto,Venditti Adriano,Martinelli Giovanni,Cerchione Claudio

Publisher

Edizioni Minerva Medica

Subject

General Medicine

Link

https://www.minervamedica.it/pdf.php?cod=R10Y2020N05A0386

Reference62 articles.

1. Genomic Classification and Prognosis in Acute Myeloid Leukemia

2. Genomics of Acute Myeloid Leukemia Diagnosis and Pathways

3. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel

4. Conditioning Intensity, Pre-Transplant Flow Cytometric Measurable Residual Disease, and Outcome in Adults with Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation

5. MINIMAL RESIDUAL DISEASE IN ACUTE MYELOID LEUKEMIA OF ADULTS: DETERMINATION, PROGNOSTIC IMPACT AND CLINICAL APPLICATIONS.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Editorial: Acute myeloid leukemia (AML): Is it time for MRD-driven treatment?;Frontiers in Oncology;2022-09-09

2. Diagnostic Workup of Acute Myeloid Leukemia: What Is Really Necessary? An Italian Survey;Frontiers in Oncology;2022-02-17

3. A deep learning method and device for bone marrow imaging cell detection;Annals of Translational Medicine;2022-02

4. Safety of FLT3 inhibitors in patients with acute myeloid leukemia;Expert Review of Hematology;2021-08-30

5. Acute leukemias in 2020: state of the art;Minerva Medica;2020-11